Clinical Trials Browser

Cirrhosis, Familial, with Pulmonary Hypertension × Clear all

NCT06735560 2026-05-13

ELEGANCE

Phase NA Recruiting

EndocrineGastrointestinalNET

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

NCT05286814 2026-05-04

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Phase 2 Recruiting

EndocrineGastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Bile Duct Neoplasms, Colorectal Neoplasms, Adrenocortical Carcinoma, Cholangiocarcinoma

NCT06777316 2026-04-17

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Phase 1/2 Active not recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07479264 2026-03-18

A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07224737 2026-03-13

EXOMIC

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Recurrence, Cholangiocarcinoma

NCT07225452 2026-03-13

LUMIC

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Liver Neoplasms, Cholangiocarcinoma

NCT06859684 2026-03-09

HAIC-quad

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06739252 2026-01-28

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Phase 2 Terminated

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma, Klatskin Tumor

NCT07353827 2026-01-20

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07337850 2026-01-13

FAPi-2

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07328919 2026-01-09

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

Phase 3 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

Phase 2 Completed

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06925516 2025-11-28

ACADEMY

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07153783 2025-11-18

Interventional AI-Human Collaboration for Liver Tumor Diagnosis

Phase NA Completed

10,333 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cysts, Carcinoma, Hepatocellular, Cholangiocarcinoma, Focal Nodular Hyperplasia

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

Phase NA Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07176962 2025-09-16

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Disease, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07161869 2025-09-09

POELH-III

Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Biliary Tract Neoplasms, Common Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07128290 2025-08-17

PEHRICCA

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07070700 2025-08-12

CASTLE-ZS-02

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07043348 2025-07-20

ISTAR-04

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07063888 2025-07-14

A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06946849 2025-04-27

SED-RO-ICC

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06888063 2025-03-21

PUMP IV

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06862934 2025-03-06

iCOLA

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06852287 2025-02-28

GOLD-HAIC

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Gallbladder Neoplasms, Cholangiocarcinoma

NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

Phase 2 Recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06648525 2024-10-18

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Phase 2 Not yet recruiting

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT01917370 2013-08-06

icc

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma